Proteoforms, the diverse molecular variants of proteins, are key to understanding cellular functions, disease mechanisms, and ...

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...

Explore how proteomics enables personalized medicine by improving patient stratification, treatment response, and diagnostics ...

Metabolic Dysfunction-Associated Steatotic Liver Disease（MASLD） is characterized by excessive accumulation of lipids in hepatocytes and is closely ...

Explore how proteomics in biomarker discovery accelerates diagnostic assay development and improves clinical validation.

Monoclonal antibodies have become one of the most established and clinically successful therapeutic modalities, supported by ...

Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor ...

Once the active ingredient is defined, an Applicant must select which patent, or patents, to put forward for extension. The statute permits only one PTE per regulatory review period, so the choice is ...

This multidisciplinary project integrates computational biology, structural modelling, population genomics, and AI. It will provide new mechanistic insights into how coding variation and PTMs ...

Explore how proteomics supports pre-symptomatic disease detection, from mass spectrometry advances to multi-omics models and clinical validation challenges.

Research led by Penn Dental's Henry Daniell investigates the use of a lettuce-based, plant-encapsulated delivery platform as ...